Physician profile
Fabio Vasquez
NPI 1528068483
$4,776.44
in general payments reported to CMS, 2019-2025
16 companies · $19.29 in 2025
The $19.29 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.30 · 2020: $1,578 · 2021: $3,048 · 2022: $17.44 · 2024: $21.86 · 2025: $19.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,600.72 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $738.48 | 2020-2021 | |
| Lilly USA, LLC | $638.06 | 2020-2021 | |
| Allergan, INC. | $332.83 | 2020 | |
| Abbvie INC. | $325.80 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.76 | 2019-2021 | |
| Novo Nordisk INC | $257.99 | 2020-2021 | |
| Esperion Therapeutics, INC. | $221.91 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $99.21 | 2020-2025 | Spravato |
| Pfizer INC. | $96.79 | 2020-2021 | |
| Amarin Pharma, INC. | $59.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $42.54 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $33.75 | 2021 | |
| Abbott Laboratories | $16.16 | 2021 | |
| Horizon Therapeutics Plc | $12.60 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabio Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.